The mechanisms of CML evolution to blast crisis are complex and may implicate secondary chromosomal changes that may contribute to the malignant phenotype and these include duplication of the Ph chromosome, trisomy 8, and mutations or deletions of tumor-suppressor genes such as p53 or p16. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.